The global biobanking market is expected to grow from USD 3.5 billion in 2017 to USD 5.2 billion by 2030, at a CAGR of 6.6% during the forecast period. The market is driven by factors such as increasing prevalence of chronic diseases and rising demand for personalized medicine, which are driving the need for biobanks and their services. The equipment segment accounted for the largest share of the global biobanking market in 2017, followed by consumables and biobanks. The consumables segment is expected to grow at a higher CAGR than other segments during the forecast period due to increasing demand for reagents used in research laboratories across various industries such as pharmaceuticals, life sciences, academia, and government agencies.
- Biobanks are also used for clinical trials in the pharmaceutical industry.
- The increasing number of diseases that have no cure or treatment options is driving the growth of biobanking market.
- Increasing government funding for research and development activities.
Industry Growth Insights published a new data on “Biobanking Market”. The research report is titled “Biobanking Market research by Types (Equipment, Consumable, Biobankin), By Applications (Virtual Biobanks, Tissue Biobanks, Population Biobanks), By Players/Companies Beckman Coulter, Thermo Fisher, Panasonic, Sigma-Aldrich, SOL Group, Promega, BD, Brooks Life Science, QIAGEN, Tecan Group, Lifeline Scientific, So-Low, LVL Technologies, DNA Genotek, Micronic, Askion, Biolife Solutions, Cryo Bio System, BioRep, Biobankin”.
Scope Of The Report
Report Attributes
Report Details
Report Title
Biobanking Market Research Report
By Type
Equipment, Consumable, Biobankin
By Application
Virtual Biobanks, Tissue Biobanks, Population Biobanks
By Companies
Beckman Coulter, Thermo Fisher, Panasonic, Sigma-Aldrich, SOL Group, Promega, BD, Brooks Life Science, QIAGEN, Tecan Group, Lifeline Scientific, So-Low, LVL Technologies, DNA Genotek, Micronic, Askion, Biolife Solutions, Cryo Bio System, BioRep, Biobankin
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
242
Number of Tables & Figures
170
Customization Available
Yes, the report can be customized as per your need.
Global Biobanking Market Report Segments:
The global Biobanking market is segmented on the basis of:
Types
Equipment, Consumable, Biobankin
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Virtual Biobanks, Tissue Biobanks, Population Biobanks
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Beckman Coulter
- Thermo Fisher
- Panasonic
- Sigma-Aldrich
- SOL Group
- Promega
- BD
- Brooks Life Science
- QIAGEN
- Tecan Group
- Lifeline Scientific
- So-Low
- LVL Technologies
- DNA Genotek
- Micronic
- Askion
- Biolife Solutions
- Cryo Bio System
- BioRep
- Biobankin
Highlights of The Biobanking Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Equipment
- Consumable
- Biobankin
- By Application:
- Virtual Biobanks
- Tissue Biobanks
- Population Biobanks
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Biobanking Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Biobanking is a term used to describe the process of collecting and storing biological samples for future study. This can include blood, saliva, hair, or other body fluids. Biobanks are often used to study diseases or genetic traits.
Some of the major companies in the biobanking market are Beckman Coulter, Thermo Fisher, Panasonic, Sigma-Aldrich, SOL Group, Promega, BD, Brooks Life Science, QIAGEN, Tecan Group, Lifeline Scientific, So-Low, LVL Technologies, DNA Genotek, Micronic, Askion, Biolife Solutions, Cryo Bio System, BioRep, Biobankin.
The biobanking market is expected to grow at a compound annual growth rate of 6.6%.
1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Biobanking Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Biobanking Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Biobanking Market - Supply Chain
4.5. Global Biobanking Market Forecast
4.5.1. Biobanking Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Biobanking Market Size (000 Units) and Y-o-Y Growth
4.5.3. Biobanking Market Absolute $ Opportunity
5. Global Biobanking Market Analysis and Forecast by Type
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Type
5.2.2. Y-o-Y Growth Projections by Type
5.3. Biobanking Market Size and Volume Forecast by Type
5.3.1. Equipment
5.3.2. Consumable
5.3.3. Biobankin
5.4. Absolute $ Opportunity Assessment by Type
5.5. Market Attractiveness/Growth Potential Analysis by Type
6. Global Biobanking Market Analysis and Forecast by Application
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Application
6.2.2. Y-o-Y Growth Projections by Application
6.3. Biobanking Market Size and Volume Forecast by Application
6.3.1. Virtual Biobanks
6.3.2. Tissue Biobanks
6.3.3. Population Biobanks
6.4. Absolute $ Opportunity Assessment by Application
6.5. Market Attractiveness/Growth Potential Analysis by Application
7. Global Biobanking Market Analysis and Forecast by Sales Channel
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Sales Channel
7.2.2. Y-o-Y Growth Projections by Sales Channel
7.3. Biobanking Market Size and Volume Forecast by Sales Channel
7.3.1. Manufacturer/Distributor/Service Provider
7.3.2. Aftermarket
7.4. Absolute $ Opportunity Assessment by Sales Channel
7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel
8. Global Biobanking Market Analysis and Forecast by Region
8.1. Market Trends
8.2. Introduction
8.2.1. Basis Point Share (BPS) Analysis by Region
8.2.2. Y-o-Y Growth Projections by Region
8.3. Biobanking Market Size and Volume Forecast by Region
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. Asia Pacific
8.3.5. Middle East and Africa (MEA)
8.4. Absolute $ Opportunity Assessment by Region
8.5. Market Attractiveness/Growth Potential Analysis by Region
8.6. Global Biobanking Demand Share Forecast, 2019-2026
9. North America Biobanking Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.2. North America Biobanking Market Size and Volume Forecast by Country
9.2.1. U.S.
9.2.2. Canada
9.3. Absolute $ Opportunity Assessment by Country
9.4. North America Biobanking Market Size and Volume Forecast by Application
9.4.1. Virtual Biobanks
9.4.2. Tissue Biobanks
9.4.3. Population Biobanks
9.5. Basis Point Share (BPS) Analysis by Application
9.6. Y-o-Y Growth Projections by Application
9.7. North America Biobanking Market Size and Volume Forecast by Type
9.7.1. Equipment
9.7.2. Consumable
9.7.3. Biobankin
9.8. Basis Point Share (BPS) Analysis by Type
9.9. Y-o-Y Growth Projections by Type
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.10.4. By Sales Channel
9.11. North America Biobanking Demand Share Forecast, 2019-2026
10. Latin America Biobanking Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Latin America Average Pricing Analysis
10.2. Latin America Biobanking Market Size and Volume Forecast by Country
10.2.1. Brazil
10.2.2. Mexico
10.2.3. Rest of Latin America
10.3. Absolute $ Opportunity Assessment by Country
10.4. Latin America Biobanking Market Size and Volume Forecast by Application
10.4.1. Virtual Biobanks
10.4.2. Tissue Biobanks
10.4.3. Population Biobanks
10.5. Basis Point Share (BPS) Analysis by Application
10.6. Y-o-Y Growth Projections by Application
10.7. Latin America Biobanking Market Size and Volume Forecast by Type
10.7.1. Equipment
10.7.2. Consumable
10.7.3. Biobankin
10.8. Basis Point Share (BPS) Analysis by Type
10.9. Y-o-Y Growth Projections by Type
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.10.4. By Sales Channel
10.11. Latin America Biobanking Demand Share Forecast, 2019-2026
11. Europe Biobanking Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Europe Average Pricing Analysis
11.2. Europe Biobanking Market Size and Volume Forecast by Country
11.2.1. Germany
11.2.2. France
11.2.3. Italy
11.2.4. U.K.
11.2.5. Spain
11.2.6. Russia
11.2.7. Rest of Europe
11.3. Absolute $ Opportunity Assessment by Country
11.4. Europe Biobanking Market Size and Volume Forecast by Application
11.4.1. Virtual Biobanks
11.4.2. Tissue Biobanks
11.4.3. Population Biobanks
11.5. Basis Point Share (BPS) Analysis by Application
11.6. Y-o-Y Growth Projections by Application
11.7. Europe Biobanking Market Size and Volume Forecast by Type
11.7.1. Equipment
11.7.2. Consumable
11.7.3. Biobankin
11.8. Basis Point Share (BPS) Analysis by Type
11.9. Y-o-Y Growth Projections by Type
11.10. Market Attractiveness/Growth Potential Analysis
11.10.1. By Country
11.10.2. By Product Type
11.10.3. By Application
11.10.4. By Sales Channel
11.11. Europe Biobanking Demand Share, 2019-2026
12. Asia Pacific Biobanking Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Asia Pacific Average Pricing Analysis
12.2. Asia Pacific Biobanking Market Size and Volume Forecast by Country
12.2.1. China
12.2.2. Japan
12.2.3. South Korea
12.2.4. India
12.2.5. Australia
12.2.6. Rest of Asia Pacific (APAC)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Asia Pacific Biobanking Market Size and Volume Forecast by Application
12.4.1. Virtual Biobanks
12.4.2. Tissue Biobanks
12.4.3. Population Biobanks
12.5. Basis Point Share (BPS) Analysis by Application
12.6. Y-o-Y Growth Projections by Application
12.7. Asia Pacific Biobanking Market Size and Volume Forecast by Type
12.7.1. Equipment
12.7.2. Consumable
12.7.3. Biobankin
12.8. Basis Point Share (BPS) Analysis by Type
12.9. Y-o-Y Growth Projections by Type
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.10.4. By Sales Channel
12.11. Asia Pacific Biobanking Demand Share, 2019-2026
13. Middle East & Africa Biobanking Market Analysis and Forecast
13.1. Introduction
13.1.1. Basis Point Share (BPS) Analysis by Country
13.1.2. Y-o-Y Growth Projections by Country
13.1.3. Asia Pacific Average Pricing Analysis
13.2. Middle East & Africa Biobanking Market Size and Volume Forecast by Country
13.2.1. Saudi Arabia
13.2.2. South Africa
13.2.3. UAE
13.2.4. Rest of Middle East & Africa (MEA)
13.3. Absolute $ Opportunity Assessment by Country
13.4. Middle East & Africa Biobanking Market Size and Volume Forecast by Application
13.4.1. Virtual Biobanks
13.4.2. Tissue Biobanks
13.4.3. Population Biobanks
13.5. Basis Point Share (BPS) Analysis by Application
13.6. Y-o-Y Growth Projections by Application
13.7. Middle East & Africa Biobanking Market Size and Volume Forecast by Type
13.7.1. Equipment
13.7.2. Consumable
13.7.3. Biobankin
13.8. Basis Point Share (BPS) Analysis by Type
13.9. Y-o-Y Growth Projections by Type
13.10. Market Attractiveness/Growth Potential Analysis
13.10.1. By Country
13.10.2. By Product Type
13.10.3. By Application
13.10.4. By Sales Channel
13.11. Middle East & Africa Biobanking Demand Share, 2019-2026
14. Competition Landscape
14.1. Global Biobanking Market: Market Share Analysis
14.2. Biobanking Distributors and Customers
14.3. Biobanking Market: Competitive Dashboard
14.4. Company Profiles (Details Overview, Financials, Developments, Strategy)
14.4.1. Beckman Coulter
14.4.1.1. Overview
14.4.1.2. Financials
14.4.1.3. Developments
14.4.1.4. Strategic Outlook
14.4.2. Thermo Fisher
14.4.2.1. Overview
14.4.2.2. Financials
14.4.2.3. Developments
14.4.2.4. Strategic Outlook
14.4.3. Panasonic
14.4.3.1. Overview
14.4.3.2. Financials
14.4.3.3. Developments
14.4.3.4. Strategic Outlook
14.4.4. Sigma-Aldrich
14.4.4.1. Overview
14.4.4.2. Financials
14.4.4.3. Developments
14.4.4.4. Strategic Outlook
14.4.5. SOL Group
14.4.5.1. Overview
14.4.5.2. Financials
14.4.5.3. Developments
14.4.5.4. Strategic Outlook
14.4.6. Promega
14.4.6.1. Overview
14.4.6.2. Financials
14.4.6.3. Developments
14.4.6.4. Strategic Outlook
14.4.7. BD
14.4.7.1. Overview
14.4.7.2. Financials
14.4.7.3. Developments
14.4.7.4. Strategic Outlook
14.4.8. Brooks Life Science
14.4.8.1. Overview
14.4.8.2. Financials
14.4.8.3. Developments
14.4.8.4. Strategic Outlook
14.4.9. QIAGEN
14.4.9.1. Overview
14.4.9.2. Financials
14.4.9.3. Developments
14.4.9.4. Strategic Outlook
14.4.10. Tecan Group
14.4.10.1. Overview
14.4.10.2. Financials
14.4.10.3. Developments
14.4.10.4. Strategic Outlook
14.4.11. Lifeline Scientific
14.4.11.1. Overview
14.4.11.2. Financials
14.4.11.3. Developments
14.4.11.4. Strategic Outlook
14.4.12. So-Low
14.4.12.1. Overview
14.4.12.2. Financials
14.4.12.3. Developments
14.4.12.4. Strategic Outlook
14.4.13. LVL Technologies
14.4.13.1. Overview
14.4.13.2. Financials
14.4.13.3. Developments
14.4.13.4. Strategic Outlook
14.4.14. DNA Genotek
14.4.14.1. Overview
14.4.14.2. Financials
14.4.14.3. Developments
14.4.14.4. Strategic Outlook
14.4.15. Micronic
14.4.15.1. Overview
14.4.15.2. Financials
14.4.15.3. Developments
14.4.15.4. Strategic Outlook
14.4.16. Askion
14.4.16.1. Overview
14.4.16.2. Financials
14.4.16.3. Developments
14.4.16.4. Strategic Outlook
14.4.17. Biolife Solutions
14.4.17.1. Overview
14.4.17.2. Financials
14.4.17.3. Developments
14.4.17.4. Strategic Outlook
14.4.18. Cryo Bio System
14.4.18.1. Overview
14.4.18.2. Financials
14.4.18.3. Developments
14.4.18.4. Strategic Outlook
14.4.19. BioRep
14.4.19.1. Overview
14.4.19.2. Financials
14.4.19.3. Developments
14.4.19.4. Strategic Outlook
14.4.20. Biobankin
14.4.20.1. Overview
14.4.20.2. Financials
14.4.20.3. Developments
14.4.20.4. Strategic Outlook